King's Ransom
Own the building blocks of our technological future. This collection features carefully selected companies mining and processing rare earth elements - the irreplaceable ingredients powering everything from smartphones to electric vehicles. Handpicked by our expert analysts to capitalize on growing global demand.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
MP Materials Corp.
MP
Current price
$69.29
As the owner and operator of the Mountain Pass facility in California, it is the largest and most crucial rare earth mining and processing site in the...
As the owner and operator of the Mountain Pass facility in California, it is the largest and most crucial rare earth mining and processing site in the Western Hemisphere.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Rare earth elements are the unsung heroes behind modern technology. As demand for electric vehicles, renewable energy, and advanced electronics grows, these limited materials become increasingly valuable. We've identified companies positioned to benefit from this accelerating global competition for tech's essential ingredients.
What You Need to Know
This portfolio focuses on miners and processors with direct operational control of rare earth elements and strategic metals. These stocks can be volatile but offer significant growth potential as nations worldwide seek to secure supply chains independent from dominant producers, creating a powerful catalyst for sector growth.
Why These Stocks
We've selected companies with established production facilities or near-term development projects across the rare earth supply chain. This mix provides exposure to different stages of extraction, processing, and commercialization, prioritizing those with significant projects in regions seeking supply chain independence.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+28.20%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 28.2% over the next year.
Stocks Rated Buy by Analysts
12 of 13 assets in this group are rated Buy by professional analysts.
Group Growth vs Bank interest
This group averaged a 8.8% return last month, beating the typical 4% bank rate.
Why You'll Want to Watch These Stocks
Supply Chain Revolution
Nations are racing to secure their own rare earth supplies, reducing dependence on single sources. This geopolitical shift creates massive opportunities for companies developing new production outside traditional markets.
Hidden Tech Essentials
These aren't household names, but they produce the irreplaceable ingredients in nearly every device you own. As tech demand grows, so does the need for the rare minerals these companies control.
Green Energy's Secret Ingredient
Want to invest in clean energy's future? These companies provide the critical materials needed for EVs, wind turbines, and energy storage - positioning them at the foundation of the green revolution.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Beyond The App Store: Europe's New Rules
Following regulatory pressure from the European Union, Google has revised its Play Store rules to permit alternative payment systems. This change creates a new investment opportunity in companies poised to benefit from a more open mobile app ecosystem.
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Frequently Asked Questions
Everything you need to know about the product and billing.